11.01.06j, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids
Independence Blue Cross reissued medical policy 11.01.06j on bone-anchored (osseointegrated) hearing aids and implantable middle ear hearing aids, effective 05/27/2026. Five new CPT codes (0951T, 0952T, 0953T, 0954T, 0955T) were added to the Experimental/Investigational section as of 07/01/2025, meaning these codes are not covered. The policy clarifies that bone-anchored hearing aids remain medically necessary for qualifying patients with conductive/mixed hearing loss or single-sided sensorineural deafness, while implantable middle ear hearing aids remain experimental and non-covered.